Quick Read

Heart failure is not simply a weak heart. It is a clinical syndrome in which the heart cannot meet the body’s needs without abnormal filling pressures, impaired output, or both. The modern disease state includes more than ejection fraction: symptoms, congestion, perfusion, structure, biomarkers, rhythm, kidney function, exercise capacity and trajectory all matter.

The distinct Medicine Web job is: symptoms or high-risk cardiac state → confirm heart-failure syndrome and phenotype → identify congestion/perfusion and precipitant → acute stabilisation where needed → long-term disease-modifying therapy → rhythm/device/valve/revascularisation handoffs where appropriate → rehabilitation → advanced-heart-failure assessment when ordinary routes fail → transplant/mechanical support/palliative decisions → longitudinal human return.

Wait, What? A Normal or Preserved Ejection Fraction Does Not Rule Out Heart Failure

The 2026 Second Universal Definition of Heart Failure moved away from treating ejection fraction as the entire disease. Heart failure may occur with reduced or preserved ejection fraction, and a person whose ejection fraction later improves still carries a heart-failure history and relapse risk.

Core anti-collapse rules: breathlessness ≠ heart failure; oedema ≠ heart failure automatically; preserved EF ≠ normal heart; improved EF ≠ cured forever; diuresis ≠ disease modified; hospital discharge ≠ congestion risk ended.

The Heart Failure Tube

Risk/structural heart disease → symptoms/signs → imaging + biomarkers + alternative-cause assessment → phenotype → congestion/perfusion state → acute or chronic route → diuresis/haemodynamic stabilisation where required → disease-modifying therapy → device/valve/coronary/rhythm handoffs where indicated → rehabilitation → repeat function and congestion receipt → advanced-heart-failure gate → mechanical support/transplant/palliative route → long-term return.

1. The Owner Is the Heart-Failure Trajectory

The Cardiovascular Medicine Web owns broad heart and vascular disease. Heart Failure & Advanced Heart Care owns the specific syndrome where cardiac dysfunction produces congestion, inadequate output, recurrent decompensation or advanced pump failure requiring a coordinated longitudinal route.

2. Symptoms Need Mechanism

Breathlessness, fatigue, reduced exercise tolerance and leg swelling can arise from heart failure, lung disease, anaemia, kidney disease, deconditioning, venous disease or combinations. The diagnosis therefore needs supporting evidence rather than symptom labels alone.

3. Congestion and Perfusion Are Different Axes

A patient can be fluid overloaded yet maintain adequate blood pressure, or can have poor perfusion with little visible oedema. Treatment urgency and choice depend on whether the dominant problem is congestion, low output, both, or neither.

For eduKateAI, useful fields include weight trend, oedema, lung congestion, blood pressure, heart rate, urine output, renal function, perfusion signs and symptom trajectory.

4. Acute Decompensation Is a State Change, Not a Separate Person

Heart failure may destabilise because of infection, arrhythmia, ischaemia, uncontrolled blood pressure, medication interruption, renal deterioration, valve disease, dietary/fluid issues or progression of the underlying heart disease.

The correction task is treat the decompensation + identify the precipitant + restore the chronic prevention route.

5. Diuretics Remove Congestion; They Do Not Replace Disease-Modifying Therapy

Diuretics can relieve fluid overload and improve symptoms, but long-term care also depends on therapies that reduce future hospitalisation, progression and mortality according to heart-failure phenotype and current guideline evidence.

Anti-collapse rule: feels less breathless ≠ underlying risk fully treated.

6. Kidney Function and Heart Failure Are Coupled

Congestion, low perfusion, diuretics, renin-angiotensin system therapies and other medicines can change creatinine and electrolytes. A change in kidney function therefore has to be interpreted in the context of the whole haemodynamic state rather than in isolation.

7. Rhythm Can Cause or Worsen Heart Failure

Atrial fibrillation, rapid tachyarrhythmias, bradyarrhythmias and conduction disease can worsen pump function or symptoms. The Cardiac Electrophysiology & Rhythm Management Web owns rhythm diagnosis, ablation and rhythm-device therapy.

8. Structural Disease Can Be the Upstream Driver

Coronary disease, valve disease, congenital disease and cardiomyopathy can all lead to heart failure. When a surgically or catheter-addressable lesion drives the syndrome, ownership moves to the appropriate structural intervention while Heart Failure preserves the pump and congestion state.

9. Exercise Capacity Is a Functional Biomarker

A patient may look stable at rest while being unable to walk ordinary distances or climb stairs. Exercise tolerance, frailty, muscle loss and recovery after admission are therefore clinically important.

The Rehabilitation & Allied Health Web owns functional restoration and participation.

10. Devices Are Different Jobs

Selected patients may benefit from implantable defibrillators, resynchronisation therapy, temporary mechanical support or durable ventricular assist devices. These technologies solve different risks and should not collapse into “heart device”.

The Durable Mechanical Circulatory Support & VAD Web owns long-term pump support.

11. Advanced Heart Failure Is a Destination Question

Recurrent admissions, progressive symptoms, intolerance of standard therapy, end-organ dysfunction or severe exercise limitation can indicate that ordinary chronic management is no longer enough. The care question becomes whether transplant, durable mechanical support, palliative-focused care or another advanced route best matches the patient’s biology and goals.

12. Transplantation Is a Separate System

The Transplantation Medicine Web owns donor allocation, matching, graft state, immunosuppression and post-transplant survival. Heart Failure owns the question of when native cardiac function has become insufficient enough to enter that system.

13. Evidence, Uncertainty and Correction

Heart-failure evidence comes from symptoms, examination, imaging, natriuretic peptides and other biomarkers, ECG/rhythm, kidney function, haemodynamics and longitudinal response. The 2026 universal definition explicitly emphasises phenotype and mimics, so discordant evidence should prompt re-evaluation rather than forced classification.

The correction loop is initial phenotype → treatment → congestion/function/biomarker receipt → compare expected with observed → investigate precipitant or alternative cause → adjust therapy or destination.

14. RFE: Did the Heart-Failure System Return Capacity to the Human?

The Medicine RFE asks whether timely, evidence-grounded and ethically authorised help reaches the human and improves outcomes without preventable harm. In heart failure, success means not only removing fluid or improving an echocardiogram, but reducing avoidable decompensation, protecting organ function, restoring activity and sleep, preserving independence, and escalating to advanced therapy only when its expected benefit matches the person’s goals and biological state.

eduKateAI Heart Failure Tube Card

• TRIGGER: dyspnoea, oedema, fatigue, admission or structural risk?
• PHENOTYPE: reduced, preserved or improved EF; what structural/functional evidence?
• CONGESTION: weight, oedema, lungs, venous pressure and symptoms?
• PERFUSION: pressure, urine output, mental state, extremity perfusion?
• PRECIPITANT: rhythm, infection, ischaemia, valve, pressure, renal or treatment interruption?
• THERAPY: decongestion plus current disease-modifying pathway?
• DEVICE/STRUCTURE: EP, valve, coronary, congenital or mechanical-support handoff?
• FUNCTION: walking, sleep, self-care, frailty and exercise capacity?
• ADVANCED GATE: recurrent admissions, progressive end-organ dysfunction or severe limitation?
• DESTINATION: chronic care, VAD, transplant, palliative focus or combined route?
• HUMAN RETURN: independence, work, relationships and quality of life?

Canonical External Sources

• AHA/ACC/ESC/WHF — Second Universal Definition of Heart Failure (2026)
• American Heart Association — Heart Failure

Educational boundary: This page explains heart-failure information architecture. It does not diagnose heart failure, interpret personal echocardiograms or biomarkers, prescribe medicines or diuretics, determine device/transplant eligibility, or replace urgent cardiovascular assessment.